Xingang Now we are the main manufacturer of Rifamycin derivatives and anti-tb drugs in the world.Main products are rifampicin,rifaximin,rifamycin、rifapentine、 S,rifamycin S sodium,etc.
more >
Year of Establishment:
1989
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
N;
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
N;
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Advantage Description: